Therefore, upregulation of SGK3, which we observed in our models of Akt‐sensitive breast cancer cell lines, could serve as a strategy to circumvent inhibition of Class I PI3K as well as Akt isoforms and provide adaptive resistance response. This evidence concerns the gene AKT1 and breast carcinoma.